Joubert syndrome with oculorenal defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2318OMIM:243910Q04.3
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Joubert syndrome with oculorenal defect, also known as Joubert syndrome type B or cerebello-oculo-renal syndrome, is a rare genetic disorder belonging to the group of Joubert syndrome and related disorders (JSRD). It is characterized by the hallmark 'molar tooth sign' on brain MRI, which reflects cerebellar vermis hypoplasia and abnormal brainstem structures. This neurological finding is accompanied by both ocular and renal abnormalities, distinguishing this subtype from other forms of Joubert syndrome. The condition primarily affects the central nervous system, eyes, and kidneys. Key neurological features include hypotonia (low muscle tone) in infancy, developmental delay, intellectual disability, abnormal breathing patterns (episodic hyperpnea/apnea), and ataxia (impaired coordination). Ocular manifestations include retinal dystrophy (such as Leber congenital amaurosis or retinitis pigmentosa), coloboma, and oculomotor apraxia. Renal involvement typically presents as nephronophthisis, a progressive tubulointerstitial kidney disease that can lead to chronic kidney failure, or less commonly as cystic kidney disease. Some patients may also exhibit other features such as nystagmus and strabismus. There is currently no cure for Joubert syndrome with oculorenal defect. Management is supportive and multidisciplinary, involving neurological, ophthalmological, and nephrological monitoring. Early intervention programs including physical therapy, occupational therapy, and speech therapy are important for optimizing developmental outcomes. Renal function must be monitored regularly, as nephronophthisis may progress to end-stage renal disease requiring dialysis or kidney transplantation. Genetic counseling is recommended for affected families. The condition is caused by mutations in several genes involved in ciliary function, including CEP290, TMEM67 (MKS3), RPGRIP1L, CC2D2A, and others, reflecting its classification as a ciliopathy.

Also known as:

Clinical phenotype terms— hover any for plain English:

Molar tooth sign on MRIHP:0002419Biparietal narrowingHP:0004422
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

1 available

Dermacure

UREA 41%· Oncora Pharma, LLC

Urea is useful for the treatment of hyperkeratotic conditions such as corns

No actively recruiting trials found for Joubert syndrome with oculorenal defect at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Joubert syndrome with oculorenal defect community →

No specialists are currently listed for Joubert syndrome with oculorenal defect.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Joubert syndrome with oculorenal defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Joubert syndrome with oculorenal defectForum →

No community posts yet. Be the first to share your experience with Joubert syndrome with oculorenal defect.

Start the conversation →

Latest news about Joubert syndrome with oculorenal defect

Disease timeline:

New recruiting trial: Combined Oral Contraceptive Pill and Resistance Starch

A new clinical trial is recruiting patients for Joubert syndrome with oculorenal defect

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Joubert syndrome with oculorenal defect

What is Joubert syndrome with oculorenal defect?

Joubert syndrome with oculorenal defect, also known as Joubert syndrome type B or cerebello-oculo-renal syndrome, is a rare genetic disorder belonging to the group of Joubert syndrome and related disorders (JSRD). It is characterized by the hallmark 'molar tooth sign' on brain MRI, which reflects cerebellar vermis hypoplasia and abnormal brainstem structures. This neurological finding is accompanied by both ocular and renal abnormalities, distinguishing this subtype from other forms of Joubert syndrome. The condition primarily affects the central nervous system, eyes, and kidneys. Key neurolo

How is Joubert syndrome with oculorenal defect inherited?

Joubert syndrome with oculorenal defect follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Joubert syndrome with oculorenal defect typically begin?

Typical onset of Joubert syndrome with oculorenal defect is neonatal. Age of onset can vary across affected individuals.